Validation Study of the Claims‐Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study
Pharmacoepidemiology and Drug Safety · 2024-11 · 33 (11)
DOI: 10.1002/pds.70032 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 25.10.2024. Verfasst von Taku Chikamochi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Ja…. Hauptthemen laut MEDLINE: COVID-19, Algorithms, International Classification of Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Purpose
We validated claims‐based algorithms using the International Classification of Diseases, Tenth Revision (ICD‐10) to identify patients with the first‐ever coronavirus disease (COVID‐19) onset between May 2020 and August 2022.
Methods
The study cohort was comprised of residents of one municipality enrolled in a public insurance program. This study used data provided by the municipality, including residents' insurer‐based medical claims data linked to the Health Center Real‐time Information‐Sharing System (HER‐SYS). The HER‐SYS data included positive results from COVID‐19 tests and were used as reference standards. Claims‐based algorithms #1 and #2 were U07.1, B34.2, with and without suspicious diagnoses, respectively. Claims‐based algorithms #3 and #4 were U07.1 with and without suspicious diagnoses, respectively. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each algorithm.
Results
The study cohort included 165 038 residents, including 13 402 residents were the reference standard. For the entire period, the sensitivity, specificity, PPV, and NPV were 55.7% (95% confidence interval: 54.8%–56.5%), 65.4% (65.2%–65.6%), 11.5% (11.3%–11.8%), and 98.9% (98.8%–99.0%) for Algorithm #1, and 67.0% (66.2%–67.8%), 88.1% (87.9%–88.3%), 31.6% (31.1%–32.2%), and 97.8% (97.7%–97.8%) for Algorithm #2, and 52.9% (52.0%–53.7%), 67.1% (66.9%–67.3%), 11.5% (11.2%–11.8%), and 98.3% (98.3%–98.4%) for Algorithm #3, 62.6% (61.8%–63.4%), 88.5% (88.3%–88.7%), 30.9% (30.3%–31.4%), and 97.3% (97.2%–97.4%) for Algorithm #4, respectively.
Conclusions
Our study showed that the validity of claims‐based algorithms consisting of COVID‐19‐related ICD‐10 codes to identify patients with first‐onset COVID‐19 is limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
- Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
ORCID-Profile: Chieko Ishiguro
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Chikamochi, T., Ishiguro, C., Mimura, W., Maeda, M., Murata, F., & Fukuda, H. (2024). Validation Study of the Claims‐Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study. Pharmacoepidemiology and Drug Safety, 33(11). https://doi.org/10.1002/pds.70032
Vancouver
Chikamochi T, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H. Validation Study of the Claims‐Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study. Pharmacoepidemiology and Drug Safety. 2024;33(11). doi:10.1002/pds.70032
BibTeX
@article{Chikamochi2024,
author = {Chikamochi, Taku and Ishiguro, Chieko and Mimura, Wataru and Maeda, Megumi and Murata, Fumiko and Fukuda, Haruhisa},
title = {Validation Study of the Claims‐Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
volume = {33},
number = {11},
doi = {10.1002/pds.70032}
}
EUVIMED